- Home
- KLTR vs CERS Comparison
KLTR vs CERS Comparison
Compare KLTR & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTR
- CERS
- Stock Information
- Founded
- KLTR 2006
- CERS 1991
- Country
- KLTR United States
- CERS United States
- Employees
- KLTR N/A
- CERS N/A
- Industry
- KLTR EDP Services
- CERS EDP Services
- Sector
- KLTR Technology
- CERS Technology
- Exchange
- KLTR Nasdaq
- CERS Nasdaq
- Market Cap
- KLTR 319.1M
- CERS 347.3M
- IPO Year
- KLTR 2021
- CERS 1997
- Fundamental
- Price
- KLTR $2.12
- CERS $1.27
- Analyst Decision
- KLTR Buy
- CERS Strong Buy
- Analyst Count
- KLTR 3
- CERS 2
- Target Price
- KLTR $2.83
- CERS $3.50
- AVG Volume (30 Days)
- KLTR 293.3K
- CERS 1.2M
- Earning Date
- KLTR 05-08-2025
- CERS 05-01-2025
- Dividend Yield
- KLTR N/A
- CERS N/A
- EPS Growth
- KLTR N/A
- CERS N/A
- EPS
- KLTR N/A
- CERS N/A
- Revenue
- KLTR $180,920,000.00
- CERS $185,144,000.00
- Revenue This Year
- KLTR $3.46
- CERS $22.37
- Revenue Next Year
- KLTR $3.67
- CERS $8.46
- P/E Ratio
- KLTR N/A
- CERS N/A
- Revenue Growth
- KLTR 2.40
- CERS 13.06
- 52 Week Low
- KLTR $0.76
- CERS $1.12
- 52 Week High
- KLTR $2.82
- CERS $2.54
- Technical
- Relative Strength Index (RSI)
- KLTR 48.61
- CERS 46.48
- Support Level
- KLTR $2.08
- CERS $1.21
- Resistance Level
- KLTR $2.23
- CERS $1.35
- Average True Range (ATR)
- KLTR 0.10
- CERS 0.06
- MACD
- KLTR -0.01
- CERS -0.00
- Stochastic Oscillator
- KLTR 25.45
- CERS 38.89
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.